Orion - Financial Calendar

Orion Corporation's publication schedules for financial reporting in 2017

ORION CORPORATION      STOCK EXCHANGE RELEASE 19 JULY 2016 at 11:00 a.m.
EEST


Orion Corporation's publication schedules for financial reporting in 2017


Orion Corporation will publish its Financial Statement Release 2016 on
Wednesday, 8 February 2017.

The publication dates of the Interim Reports and the Half-Yearly Report in 2017
are as follows:

Interim Report January-March 2017                     Wednesday, 26 April 2017
Half-Yearly Report January-June 2017                Wednesday, 19 July 2017
Interim Report January-September 2017              Thursday, 26 October 2017

The Financial Statements and the report of the Board of Directors 2016 will be
published on the Company's website at the latest in week 9/2017.

The Annual General Meeting is planned to be held on Wednesday, 22 March 2017 in
Helsinki.

Orion's financial reports and related presentation material are available on the
Group's website at http://www.orion.fi/investors promptly after the publishing.
The website also provides a possibility to register on Orion's mailing lists for
releases.


Orion Corporation



 Timo Lappalainen    Olli Huotari
 President and CEO   SVP, Corporate Functions



Contact person:
Tuukka Hirvonen, Communications Manager, financial communications and investor
relations
tel. +358 10 426 2721

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02101 Espoo, Finland
Homepage: www.orion.fi



Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. The core therapy areas of Orion's pharmaceutical R&D are
central nervous system (CNS) disorders, oncology and respiratory for which Orion
developes inhaled Easyhaler® pulmonary drugs.

Orion's net sales in 2015 amounted to EUR 1,016 million and the company had
about 3,400 employees. Orion's A and B shares are listed on Nasdaq Helsinki..


[HUG#2029310]